PMID: 9633032Jun 20, 1998Paper

Service-level costing of drug abuse treatment

Journal of Substance Abuse Treatment
D W AndersonG Bassin

Abstract

This paper presents a methodology for estimating costs of delivering specific substance abuse treatment services. Data collected from 13 programs indicate that the mean cost of residential treatment is $2,773 per patient per month, and outpatient treatment costs average $636 per patient per month. Data are presented on the cost patient per month for individual treatment and nontreatment services, average number of services, cost per unit of service, and intensity of services. In addition to their application to insurance benefit cost estimation, these data illustrate the costing of best-practice adolescent treatment consistent with a Center of Substance Abuse Treatment (CSAT) Treatment Improvement Protocol. In the emerging policy environment, detailed cost estimates like these will aid the design of cost-effective treatment programs, and serve the development of the substance abuse benefit in a health care reform insurance package.

References

Jan 1, 1995·Journal of Substance Abuse·T D'Aunno, T E Vaughn
Jan 1, 1995·Journal of Substance Abuse·R M EtheridgeR L Hubbard
Jan 1, 1993·Health Care Management Review·Y C Chan

❮ Previous
Next ❯

Citations

Dec 21, 2000·Current Psychiatry Reports·P G Barnett
Nov 26, 2003·Health Policy·William S Cartwright, Paul L Solano
Dec 13, 2003·Journal of Substance Abuse Treatment·Bennett W FletcherPatrick M Flynn
Nov 22, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michael T FrenchRaymond L Stephens
Dec 8, 2000·Australian and New Zealand Journal of Public Health·C SpoonerW Noffs
Apr 9, 2008·Substance Use & Misuse·Albert M WoodwardBeatrice Blacklow
Dec 26, 2015·Evaluation and Program Planning·Sujha SubramanianFrances Babcock
Dec 14, 2011·Journal of Substance Abuse Treatment·Kirk M BroomePatrick M Flynn
Nov 3, 2010·Evaluation and Program Planning·Sujha SubramanianLaura C Seeff
Aug 12, 2009·American Journal of Preventive Medicine·Sujha SubramanianJustin Trogdon
Jul 22, 2008·Evaluation and Program Planning·Gary A ZarkinAlexander J Cowell
Feb 26, 2008·Journal of Substance Abuse Treatment·Michael T FrenchLauren Tapsell
Jul 7, 2007·Journal of Substance Abuse Treatment·William S Cartwright
Oct 24, 2007·Evaluation and Program Planning·Albert WoodwardAntonio A Morgan-Lopez
Aug 22, 2013·Prevention Science : the Official Journal of the Society for Prevention Research·D Max CrowleyDamon E Jones
Sep 2, 2005·Journal of Substance Abuse Treatment·Michael T French, Michael Drummond
Mar 23, 2005·Journal of Substance Abuse Treatment·Marisa DominoSukyung Chung
Mar 29, 2001·Annual Review of Public Health·J L Sindelar, D A Fiellin
Nov 14, 2008·Drug and Alcohol Dependence·Patrick M FlynnDonald S Shepard
Jul 27, 2006·Evaluation & the Health Professions·Elizabeth M Ginexi, Thomas F Hilton
Feb 13, 2018·Prevention Science : the Official Journal of the Society for Prevention Research·D Max CrowleyRobert Plotnick
Mar 17, 2007·The American Journal of Drug and Alcohol Abuse·Farrokh Alemi, Thomas Sullivan
Jun 17, 2008·Journal of Public Health Management and Practice : JPHMP·A James Lee, Matthew R Cornish
Aug 2, 2016·Journal of Public Health Management and Practice : JPHMP·Sujha SubramanianUNKNOWN International Colorectal Cancer Screening Network
May 6, 2019·Preventing Chronic Disease·Sonja HooverFlorence Tangka
Jun 8, 2019·Preventing Chronic Disease·Florence K L TangkaSajal Chattopadhyay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.